Is Santen Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Santen Pharmaceutical pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY17 per share. Over the last 48 times between 2001 and 2024, Santen Pharmaceutical has paid JPY1277 with an average of JPY26.6 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Santen Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY1 854.00, you would have made a loss of JPY-26.50 per share or -1.43%
Yes, the average daily trading liquidity for Santen Pharmaceutical is JPY1.30 million. You should therefore be able to get in and out of your positions relatively fast.
Santen Pharmaceutical has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.40, the company's ability to pay off the debt is good. Santen Pharmaceutical has a good net profit margin of 8.82% and should have high tolerances against inflation.
We have calculated the inflation risk for Santen Pharmaceutical to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.